- Sapru, A;
- Calfee, CS;
- Liu, KD;
- Kangelaris, K;
- Hansen, H;
- Pawlikowska, L;
- Ware, LB;
- Alkhouli, MF;
- Abbot, J;
- Matthay, MA
Objective: Thombomodulin (TM) is an activator of protein C and a biomarker for endothelial injury. We hypothesized that (1) elevated plasma levels would be associated with clinical outcomes and (2) polymorphisms in the TM gene would be associated with plasma levels.